本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

GT Biopharma Inc.

2.06
-0.0800-3.74%
盘后2.060.00000.00%17:39 EDT
成交量:8.16万
成交额:16.88万
市值:648.49万
市盈率:-0.38
高:2.22
开:2.22
低:2.01
收:2.14
数据加载中...
2025/07/24

重要事件披露

Form 8-K - Current report
2025/06/27

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/06/11

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/06/11

重要事件披露

Form 8-K - Current report
2025/05/28

重要事件披露

Form 8-K - Current report
2025/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/14

重要事件披露

Form 8-K - Current report
2025/05/13

重要事件披露

Form 8-K - Current report
2025/05/06

重要事件披露

Form 8-K - Current report
2025/04/14

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/04/04

重要事件披露

Form 8-K - Current report
2025/03/12

SEC问询函

Form CORRESP - Correspondence
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/21

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/07

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/27

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/27

重要事件披露

Form 8-K - Current report
2024/12/23

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/11/28

重要事件披露

Form 8-K - Current report
2024/11/21

重要事件披露

Form 8-K - Current report